• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Counterclaims stand in whistleblower lawsuit against Boston Scientific

Counterclaims stand in whistleblower lawsuit against Boston Scientific

September 8, 2014 By Brad Perriello

Counterclaims stand in whistleblower lawsuit against Boston Scientific

Boston Scientific‘s (NYSE:BSX) breach-of-contract counterclaims will stand in a whistleblower lawsuit filed by a pair of former customer service employees over the medical device company’s Precision Plus spinal cord stimulation system, a federal judge ruled last week.

Whistleblowers Wendy Bahnsen and Carolina Fuentes in March 2011 accused Boston Scientific of submitting fraudulent Medicare and Medicaid billing claims, concealing defects and denying replacement devices, engaging in a kickbacks scheme and retaliating against employees who raised the red flag about such practices.

Boston Scientific’s counter-claim alleged that Bahnsen and Fuentes breached their employment contracts by leaking confidential information, according to court documents. Bahnsen and Fuentes rebutted that they handed over the information to government authorities in compliance with federal anti-fraud laws, and that the medical device giant was seeking only to "immunize itself from this damning and damaging evidence" by attacking the whistleblowers. They asked Judge Susan Wigenton of the U.S. District Court for New Jersey to dismiss the counter-claims, according to the documents.

But Wigenton demurred, dismissing only 2 of the 23 counter-claims on the grounds that the plaintiffs " pled with sufficient particularity facts constituting [Boston Scientific’s] alleged fraud," according to court records.

"At this stage, defendant has sufficiently pled breach of contract counterclaims. Both relators signed employment agreements, at the beginning of their employment at [Boston Scientific], requiring them to refrain from disclosing or retaining certain [Boston Scientific] confidential or proprietary information. Defendant claims that plaintiffs impermissibly ‘took, disclosed, and then published’ confidential patient claims data and proprietary business information related to the [Precision Plus] system and customer lists in their 1st amended complaint, thereby breaching their employment contracts," Wigenton wrote.

Boston Scientific lost its initial bid to have the lawsuit thrown out of court when Wigenton denied the motions and ruled that the case may proceed.

Filed Under: Legal News, Neuromodulation/Neurostimulation, News Well Tagged With: Boston Scientific, Whistleblower (qui tam) lawsuit

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy